Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome.

Walker S, Wang C, Walradt T, Hong BS, Tanner JR, Levinsohn JL, Goh G, Subtil A, Lessin SR, Heymann WR, Vonderheid EC, King BA, Lifton RP, Choi J.

Blood. 2016 Feb 18;127(7):948-51. doi: 10.1182/blood-2015-06-654277. Epub 2015 Dec 23. No abstract available.

2.

The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis.

Capriotti K, Capriotti JA, Lessin S, Wu S, Goldfarb S, Belum VR, Lacouture ME.

Br J Dermatol. 2015 Sep;173(3):842-5. doi: 10.1111/bjd.13743. Epub 2015 Jul 29. Review. No abstract available.

PMID:
25704465
3.

The Dermatology Foundation: partnerships and programs focused on the future.

Fairley JA, Krueger GG, Lessin SR, Leyden JJ, McBurney EI, Orlow SJ, Tharp MD, Voorhees JJ, Wintroub BU, Yancey KB.

J Invest Dermatol. 2013 Apr;133(4):861-2. doi: 10.1038/jid.2013.15. No abstract available.

4.

New insights into associated co-morbidities in patients with cutaneous T-cell lymphoma (mycosis fungoides).

Hodak E, Lessin S, Friedland R, Freud T, David M, Pavlovsky L, Shapiro J, Cohen AD.

Acta Derm Venereol. 2013 Jul 6;93(4):451-5. doi: 10.2340/00015555-1496.

5.

Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.

Lessin SR, Duvic M, Guitart J, Pandya AG, Strober BE, Olsen EA, Hull CM, Knobler EH, Rook AH, Kim EJ, Naylor MF, Adelson DM, Kimball AB, Wood GS, Sundram U, Wu H, Kim YH.

JAMA Dermatol. 2013 Jan;149(1):25-32. doi: 10.1001/2013.jamadermatol.541.

6.

Process and outcomes of a skin protection intervention for young adults.

Heckman CJ, Zhu F, Manne SL, Kloss JD, Collins BN, Bass SB, Lessin SR.

J Health Psychol. 2013 Apr;18(4):561-73. doi: 10.1177/1359105312449193. Epub 2012 Jul 27.

7.

The Cutaneous Lymphoma Foundation: a trusted name in the cutaneous lymphoma community.

Lessin SR.

Clin Dermatol. 2012 Jul-Aug;30(4):450; author reply 450. doi: 10.1016/j.clindermatol.2012.04.002. No abstract available.

PMID:
22682197
8.

A retrospective analysis of the Dermatology Foundation's Career Development Award Program.

Boris C, Lessin SR, Wintroub BU, Yancey KB.

J Am Acad Dermatol. 2012 Nov;67(5):969-74. doi: 10.1016/j.jaad.2012.02.032. Epub 2012 Mar 28.

PMID:
22459361
9.

Beliefs and intentions for skin protection and UV exposure in young adults.

Heckman CJ, Manne SL, Kloss JD, Bass SB, Collins B, Lessin SR.

Am J Health Behav. 2011 Nov;35(6):699-711.

10.

Skin surveillance intentions among family members of patients with melanoma.

Coups EJ, Manne SL, Jacobsen PB, Ming ME, Heckman CJ, Lessin SR.

BMC Public Health. 2011 Nov 14;11:866. doi: 10.1186/1471-2458-11-866.

11.

Clinical end points and response criteria in mycosis fungoides and S├ęzary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N, Bernengo MG, Ortiz-Romero PL, Bagot M, Estrach T, Guitart J, Knobler R, Sanches JA, Iwatsuki K, Sugaya M, Dummer R, Pittelkow M, Hoppe R, Parker S, Geskin L, Pinter-Brown L, Girardi M, Burg G, Ranki A, Vermeer M, Horwitz S, Heald P, Rosen S, Cerroni L, Dreno B, Vonderheid EC; International Society for Cutaneous Lymphomas.; United States Cutaneous Lymphoma Consortium.; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer..

J Clin Oncol. 2011 Jun 20;29(18):2598-607. doi: 10.1200/JCO.2010.32.0630. Epub 2011 May 16.

12.

Sun protection and sunbathing practices among at-risk family members of patients with melanoma.

Manne SL, Coups EJ, Jacobsen PB, Ming M, Heckman CJ, Lessin S.

BMC Public Health. 2011 Feb 21;11:122. doi: 10.1186/1471-2458-11-122.

13.

Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients.

Manne S, Jacobsen PB, Ming ME, Winkel G, Dessureault S, Lessin SR.

Health Psychol. 2010 Nov;29(6):583-93. doi: 10.1037/a0021387.

14.

The state of cutaneous lymphomas: a call to action.

Lessin SR, Porcu P.

Clin Lymphoma Myeloma Leuk. 2010 Sep;10 Suppl 2:S55-8. doi: 10.3816/CLML.2010.s.007. No abstract available.

PMID:
20826397
15.

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.

Xu XZ, Garcia MV, Li TY, Khor LY, Gajapathy RS, Spittle C, Weed S, Lessin SR, Wu H.

Mod Pathol. 2010 Feb;23(2):187-96. doi: 10.1038/modpathol.2009.157. Epub 2009 Nov 6.

16.

Alibert lymphoma: renaming mycosis fungoides.

Lessin SR.

Arch Dermatol. 2009 Feb;145(2):209-10. doi: 10.1001/archdermatol.2008.567. No abstract available.

PMID:
19221278
17.

Treatment of parapsoriasis with bexarotene 1% gel.

Lessin SR, Ross EA, Wu H.

Int J Dermatol. 2008 Dec;47(12):1325-7. doi: 10.1111/j.1365-4632.2008.03740.x. No abstract available.

PMID:
19126035
18.

Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature.

Shafer D, Wu H, Al-Saleem T, Reddy K, Borghaei H, Lessin S, Smith M.

Arch Dermatol. 2008 Sep;144(9):1155-62. doi: 10.1001/archderm.144.9.1155. Review.

PMID:
18794461
19.

A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.

O'Neill GM, Seo S, Serebriiskii IG, Lessin SR, Golemis EA.

Cancer Res. 2007 Oct 1;67(19):8975-9. Review.

20.

Cutaneous T-cell lymphoma epidemiology: patients providing the power.

Lessin SR.

Arch Dermatol. 2007 Jul;143(7):916-8. No abstract available.

PMID:
17638738

Supplemental Content

Loading ...
Support Center